Investment bank Compass Point downgraded Coinbase Inc. (COIN) stock from 'Neutral' to 'Sell', lowering the price target from $330 to $248, reflecting a 24.85% decrease. The downgrade is attributed to waning retail interest, increased competition in stablecoins, and concerns over unsustainable valuation. This follows Coinbase's weaker-than-expected second-quarter earnings, impacted by lower trading volumes and heightened competition pressures. Despite the downgrade, Coinbase shares have risen approximately 28% year-to-date but fell sharply following the announcement, dropping 5.47% to $300.77 amid increased bearish options trading, with the put/call ratio rising to 0.89. Concurrently, Bank of America maintained a 'Buy' rating on Robinhood Markets Inc. (HOOD), raising its price target to $119 after strong Q2 results, while lowering Coinbase's price target to $369 with a 'Hold' rating. Other notable analyst moves include JPMorgan and Evercore raising targets for BorgWarner (BWA) and Piper Sandler increasing the target for Cheesecake Factory (CAKE). Multiple other companies received target adjustments from various firms, reflecting a broad range of sector movements.
$XMTR -Citizens JMP raises Xometry target to $50 from $45 Market Outperform -Goldman raises target to $42 from $33 Buy -UBS raises target to $40 from $35 Neutral - $YOU -Telsey raises Clear Secure target to $37 from $32 Outperform -Goldman raises target to $37 from $33 Buy -
$UPST -Bank of America trims Upstart target to $87 from $88 Neutral - $VAC -Goldman raises Marriott Vacations target to $65 from $55 Sell - $VRTX -Guggenheim lowers Vertex Pharmaceuticals target to $546 from $558 Buy -Wells Fargo upgrades to Overweight from = Weight $460 target
$SMCI -Needham raises Super Micro Computer target to $60 from $39 Buy -Goldman raises target to $27 from $24 Sell - $SMLR -Cantor trims Semler Scientific target to $60 from $61 Overweight -